Invitro Biodegradability of Silk Fibroin/Xanthan Biopolymeric Composite Scaffolds
Source abstract
Abstract
Silk fibroin/xanthan scaffolds were prepared by blending silk fibroin and xanthan in the ratios 80SF:20Xa (SFX82), 60SF:40Xa (SFX64), and 50SF:50Xa (SFX55) using freeze drying method. In-vitro degradation behavior of the prepared scaffolds was studied for 37 days in phosphate buffer saline. The degradation rate was the function of silk fibroin, xanthan and β-crystallite contents in the silk fibroin/ xanthan composites. SFX82 degraded extremely slowly whereas SFX55 showed faster degradation rate. Hydrophilic xanthan was the main contributor of weight loss. SFX82 and SFX64 exhibited surface degradation whereas SFX55 showed bulk degradation which indicated that higher silk fibroin ratios favor surface degradation. Due to bulk degradation, SFX55 showed maximum surface roughness among the composite scaffolds. The FTIR spectrum revealed total loss of xanthan from the composites after degradation. The broad and low-intensity peaks in the FTIR spectrum of composite scaffolds confirmed reduction in β-sheet crystallite content during degradation. XRD analysis also confirmed reduction in β-sheet crystals and revealed that degraded composite scaffold had predominantly amorphous structure. The degraded scaffold showed higher porous structure than the non-degraded scaffold. The in vitro degradability testing gives a good approximation of degradation of scaffold in vivo and helps in designing a robust biopolymeric composite scaffold for tissue engineering.
Source: openaire · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Silk-based biomaterials and applications · Electrospun Nanofibers in Biomedical Applications · Bone Tissue Engineering Materials
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (37)
Show source-provided references
1. Odelius K, Anders H, Kumar S, Hakkarainen M, Ghosh A K, Bhatnagar N, Albertsson, A C. Porosity and pore size regulate the degradation product profile of polylactide. Biomacromolecules, 2011, 12, 1250–1258.10.1021/bm1015464 ↗
2. Qasim S B, Husain S, Huang Y, Pogorielov M, Deineka V, Lyndin M, Rawlinson A, Rehman I U. In-vitro and in-vivo degradation studies of freeze gelated porous chitosan blend scaffolds for tissue engineering applications. Polymer Degradation and Stability, 2017, 136, 31–38.10.1016/j.polymdegradstab.2016.11.018 ↗
3. Lu Q, Zhang B, Li M, Zuo B, Kaplan D L, Huang Y, Zhu H. Degradation mechanism and control of silk fibroin. Biomacromolecules, 2011, 12, 1080–1086.10.1021/bm101422j ↗
4. Lam C X F, Savalani M M, Teoh S H, Hutmacher D W. Dynamics of in vitro polymer degradation of polycaprolactone-based scaffolds: Accelerated versus simulated physiological conditions. Biomedical Materials, 2008, 3, 034108.10.1088/1748-6041/3/3/034108 ↗
5. Mottaghitalab F, Farokhi M, Shokrgozar M A, Atyabi F, Hosseinkhani H. Silk fibroin nanoparticle as a novel drug delivery system. Journal of Controlled Release, 2015, 206, 161–176.10.1016/j.jconrel.2015.03.020 ↗
6. Woloszyk A, Dircksen S H, Bostanci N, Muoller R, Hofmann S, Mitsiadis T A. Influence of the mechanical environment on the engineering of mineralised tissues using human dental pulp stem cells and silk fibroin scaffolds. PLOS ONE, 2014, 9, e111010.10.1371/journal.pone.0111010 ↗
7. Luangbudnark W, Viyoch J, Laupattarakasem W, Surakunprapha P, Laupattarakasem P. Properties and biocompatibility of chitosan and silk fibroin blend films for application in skin tissue engineering. Scientific World Journal, 2012, 697201.
8. Srivastava C M, Purwar R, Kannaujia R, Sharma D. Flexible silk fibroin films for wound dressing. Fibers and Polymers, 2015, 16, 1020–1030.10.1007/s12221-015-1020-y ↗
9. Thurber A E, Omenetto F G, Kaplan D L. In vivo bioresponses to silk proteins. Biomaterials, 2015, 71, 145–157.10.1016/j.biomaterials.2015.08.039 ↗
10. She Z, Zhang B, Jin C, Feng Q, Xu Y. Preparation and in vitro degradation of porous three-dimensional silk fibroin/chitosan scaffold. Polymer Degradation and Stability, 2008, 93, 1316–1322.10.1016/j.polymdegradstab.2008.04.001 ↗
11. Shera S S, Sahu S, Banik R M. Preparation of drug eluting natural composite scaffold using response surface methodology and artificial neural network approach. Tissue Engineering and Regenerative Medicine, 2018, 15, 131–143.10.1007/s13770-017-0100-z ↗
12. Bradford M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Analytical Biochemistry, 1976, 72, 248–254.10.1016/0003-2697(76)90527-3 ↗
13. Nielsen S S. Phenol-sulfuric acid method for total carbohydrates. In: Nielsen S S. ed., Food Analysis Laboratory Manual, Springer, Boston, MA, USA, 2010, 47–53.10.1007/978-1-4419-1463-7_6 ↗
14. Hu X, Kaplan D L, Cebe P. Determining beta-sheet crystallinity in fibrous proteins by thermal analysis and infrared spectroscopy. Macromolecules, 2006, 39, 6161–6170.10.1021/ma0610109 ↗
15. Kim U J, Park J, Kim H J, Wada M, Kaplan D L. Three-dimensional aqueous-derived biomaterial scaffolds from silk fibroin. Biomaterials, 2005, 26, 2775–2785.10.1016/j.biomaterials.2004.07.044 ↗
16. Koperska M A, Pawcenis D, Milczarek J M, Blachecki A, Łojewski T, Łojewska J. Fibroin degradation — Critical evaluation of conventional analytical methods. Polymer Degradation and Stability, 2015, 120, 357–367.10.1016/j.polymdegradstab.2015.07.006 ↗
17. Hu J X, Ran J B, Chen S, Jiang P, Shen X Y, Tong H. Carboxylated agarose (CA)-silk fibroin (SF) dual confluent matrices containing oriented hydroxyapatite (HA) crystals: Biomimetic organic/inorganic blends for tibia repair. Biomacromolecules, 2016, 17, 2437–2447.10.1021/acs.biomac.6b00587 ↗
18. Vasile C, Pamfil D, Râpă M, Darie-Niţš R N, Mitelut A C, Popa E E, Popescu P A, Draghici M C, Popa M E. Study of the soil burial degradation of some PLA/CS bioblends. Composite Part B: Engineering, 2018, 142, 251–262.10.1016/j.compositesb.2018.01.026 ↗
19. Andermahr J, Elsner A, Brings A E, Hensler T, Gerbershagen H, Jubel A. Reduced collagen degradation in polytraumas with traumatic brain injury causes enhanced osteogenesis. Journal of Neurotrauma, 2006, 23, 708–720.10.1089/neu.2006.23.708 ↗
20. Park S H, Gil S E, Shi H, Kim H J, Lee K, Kaplan D L. Biomaterials relationships between degradability of silk scaffolds and osteogenesis. Biomaterials, 2010, 31, 6162–6172.10.1016/j.biomaterials.2010.04.028 ↗
21. Cheng Y, Koh L D, Li D, Ji B, Han M Y, Zhang Y W. On the strength of β-sheet crystallites of Bombyx mori silk fibroin. Journal of the Royal Society Interface, 2014, 11, 20140305.10.1098/rsif.2014.0305 ↗
22. Pei Y, Liu X, Liu S, Lu Q, Liu J, Kaplan D L, Zhu H. A mild process to design silk scaffolds with reduced β-sheet structure and various topographies at the nanometer scale. Acta Biomaterialia, 2015, 13, 168–176.10.1016/j.actbio.2014.11.016 ↗
23. Zhou J, Zhang B, Liu X, Shi L, Zhu J, Wei D, Zhong J, Sun G, He D. Facile method to prepare silk fibroin/hyaluronic acid films for vascular endothelial growth factor release. Carbohydrate Polymer, 2016, 143, 301–309.10.1016/j.carbpol.2016.01.023 ↗
24. Lu Q, Hu X, Wang X, Kluge J A, Lu S, Cebe P, Kaplan D L. Water-insoluble silk films with silk I structure. Acta Biomaterialia, 2010, 6, 1380–1387.10.1016/j.actbio.2009.10.041 ↗
25. Koperska M A, Łojewski T, Łojewska J. Evaluating degradation of silk’s fibroin by attenuated total reflectance infrared spectroscopy: Case study of ancient banners from polish collections. Spectrochimica Acta Part A: Molecular Biomolecular Spectroscopy, 2015, 135, 576–582.10.1016/j.saa.2014.05.030 ↗
26. Zhang W, Huang Z L, Liao S S, Cui F Z. Nucleation sites of calcium phosphate crystals during collagen mineralization. Journal of the American Ceramic Society, 2003, 86, 1052–1054.10.1111/j.1151-2916.2003.tb03422.x ↗
27. Zhang F, Zuo B Q, Zhang H X, Bai L. Studies of electrospun regenerated SF/TSF nanofibers. Polymer, 2009, 50, 279–285.10.1016/j.polymer.2008.10.053 ↗
28. Zhang Z, Qu Y, Li X, Zhang S, Wei Q, Shi Y, Chen L. Electrophoretic deposition of tetracycline modified silk fibroin coatings for functionalization of titanium surfaces. Applied Surface Science, 2014, 303, 255–262.10.1016/j.apsusc.2014.02.160 ↗
29. Midha S, Tripathi R, Geng H, Lee P D, Ghosh S. Elucidation of differential mineralisation on native and regenerated silk matrices. Material Sciednce & Engineering-Materials for Biological Applications, 2016, 68, 663–674.10.1016/j.msec.2016.06.041 ↗
30. Wang H Y, Zhang Y Q. Processing and characterisation of a novel electropolymerized silk fibroin hydrogel membrane. Scientific Reports, 2014, 4, 6182.10.1038/srep06182 ↗
31. Ming J, Pan F, Zuo B. Influence factors analysis on the formation of silk I structure. International Journal of Biological Macromolecules, 2015, 75, 398–401.10.1016/j.ijbiomac.2015.02.002 ↗
32. Zhu J, Shao H, Hu X. Morphology and structure of electrospun mats from regenerated silk fibroin aqueous solutions with adjusting pH. International Journal of Biological Macromolecules, 2007, 41, 469–474.10.1016/j.ijbiomac.2007.06.006 ↗
33. Moser T, Celma C, Lebert A, Charrault E, Brooke R, Murphy P J, Browne G, Young R, Higgs T, Evans D. Hydrophilic organic electrodes on flexible hydrogels. ACS Applied Material & Interfaces, 2016, 8, 974–982.10.1021/acsami.5b10831 ↗
34. Loh Q L, Choong C. Three-dimensional scaffolds for tissue engineering applications: Role of porosity and pore size. Tissue Engineering Part B-Review, 2013, 19, 485–502.10.1089/ten.teb.2012.0437 ↗
35. Annabi N, Nichol J W, Zhong X, Ji C, Khademhosseini A, Dehghani F. Controlling the porosity and microarchitecture of hydrogels for tissue engineering. Tissue Engineering Part B-Review, 2010, 16, 371–383.10.1089/ten.teb.2009.0639 ↗
36. Varkey A, Venugopal E, Sugumaran P, Janarthanan G, Pillai MM, Rajendran S, Bhattacharyya A. Impact of silk fibroin-based scaffold structures on human osteoblast MG63 cell attachment and proliferation. International Journal of Nanomedicine, 2015, 10, 43–51.
37. Li J, Wang Q, Gu Y, Zhu Y, Chen L, Chen Y. Production of composite scaffold containing silk fibroin, chitosan, and gelatin for 3D cell culture and bone tissue regeneration. Medical Science Monitor, 2017, 23, 5311–5320.10.12659/MSM.905085 ↗